home Commercial policy Contacts ESG Biotech, Joint Venture Commercial Policy Contacts About company ESG Biotech is a joint venture supplying the Russian market with drugs for the treatment of hemophilia and blood coagulation disorders. The joint venture includes two companies: SG Biotech Sarl (GS Biotech Sarl), Switzerland, and JSC GS Biotech (Russia). The main objectives of ESG Biotech are to improve the health and quality of life of patients with hemophilia, as well as to increase the availability of modern drug therapy by providing the Russian market with safe and highly effective blood coagulation drugs. Every day, ESG Biotech products help thousands of people with hemophilia. Commercial policy Commercial policy of the joint venture Date of posting materials 05/13/2016 Contacts SG Biotech Sarl Address: Shire Orphan and Rare Diseases GmbH Zählerweg 18 6300 Zug Switzerland +41 41 288 40 00 JSC ES Biotech Address: Russia, 601125, Vladimir region, Petushinsky district, Volginsky , house 18 send a message Shire Orphan and Rare Diseases GmbH Zählerweg 18 6300 Zug Switzerland Russia, 601125, Vladimir region, Petushinsky district, Volginsky, house 17 info@sgbiotech.ch +41 41 288 40 00 © SG Biotech, 2016